Idera Announces FDA Orphan Drug Designation for IMO-8400 for the Treatment of Diffuse Large B-Cell Lymphoma
April 01, 2015 at 08:33 AM EDT
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and ...
